130 related articles for article (PubMed ID: 14636615)
1. Predictive value of immunohistochemical thymidylate synthase expression for histological response to Tegafur/Uracil (UFT) in oral squamous cell carcinoma.
Kawano K; Goto H; Kanda T; Yanagisawa S
Int J Oral Maxillofac Surg; 2003 Dec; 32(6):633-7. PubMed ID: 14636615
[TBL] [Abstract][Full Text] [Related]
2. Thymidylate synthase and dihydropyrimidine dehydrogenase expression in oral squamous cell carcinoma: an immunohistochemical and clinicopathologic study.
Kawasaki G; Yoshitomi I; Yanamoto S; Mizuno A
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2002 Dec; 94(6):717-23. PubMed ID: 12464897
[TBL] [Abstract][Full Text] [Related]
3. Predictive value of thymidylate synthase and dihydropyrimidine dehydrogenase expression in tumor tissue, regarding the efficacy of postoperatively administered UFT (tegafur+uracil) in patients with non-small cell lung cancer.
Miyoshi T; Kondo K; Toba H; Yoshida M; Fujino H; Kenzaki K; Sakiyama S; Takehisa M; Tangoku A
Anticancer Res; 2007; 27(4C):2641-8. PubMed ID: 17695427
[TBL] [Abstract][Full Text] [Related]
4. Thymidylate synthase expression in oral squamous cell carcinoma predicts response to S-1.
Harada K; Kawashima Y; Yoshida H; Sato M
Oncol Rep; 2006 Jun; 15(6):1417-23. PubMed ID: 16685374
[TBL] [Abstract][Full Text] [Related]
5. Clinical relevance of thymidylate synthase (TS) activity for S-1-based chemotherapy in squamous cell carcinoma of the oral cavity.
Koga M; Anegawa E; Yoh J; Tsuyama H; Sakaino H; Iwamoto O; Koga C; Kusukawa J
Br J Oral Maxillofac Surg; 2010 Mar; 48(2):88-93. PubMed ID: 19576666
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of TS-1 based treatment and expression of thymidylate synthase and dihydropyrimidine dehydrogenase on oral squamous cell carcinoma.
Obara S; Yamamoto K; Hosogai N; Yoshimura Y
Oral Oncol; 2005 Mar; 41(3):276-82. PubMed ID: 15743690
[TBL] [Abstract][Full Text] [Related]
7. [Immunohistochemical and clinicopathological study of thymidylate synthase, dihydropyrimidine dehydrogenase, and orotate phosphoribosyl transferase expression in oral cancer patients responding to UFT].
Kawasaki G; Yoshitomi I; Yanamoto S; Yamada S; Kawano T; Mizuno A
Gan To Kagaku Ryoho; 2010 Jun; 37(6):1035-9. PubMed ID: 20567103
[TBL] [Abstract][Full Text] [Related]
8. [Thymidylate synthase expression in patients with hypopharyngeal carcinoma].
Yamaoka H; Tsukuda M; Mochimatsu I; Nagahara T; Enomoto H; Kagata H; Kagesato Y; Daicho S; Mizuno H; Nishimura G; Baba Y; Kawakami K
Gan To Kagaku Ryoho; 1998 Jun; 25(7):1007-12. PubMed ID: 9644315
[TBL] [Abstract][Full Text] [Related]
9. High expression of Jun activation domain-binding protein 1 (Jab1) is a strong prognostic marker in oral squamous cell carcinoma patients treated by UFT in combination with radiation.
Harada K; Kawashima Y; Yoshida H; Sato M
Anticancer Res; 2006; 26(2B):1615-9. PubMed ID: 16619581
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical expression of thymidylate synthase as a prognostic factor and as a chemotherapeutic efficacy index in patients with colorectal carcinoma.
Tachikawa D; Arima S; Futami K
Anticancer Res; 2000; 20(6A):4103-7. PubMed ID: 11131679
[TBL] [Abstract][Full Text] [Related]
11. [Thymidylate synthase and dihydropyrimidine dehydrogenase expression and histological effects of preoperative UFT in gastric cancer patients].
Uyama R; Yoshizawa Y; Tajiri T; Endo Y; Mitsuya T; Sanada Y
Gan To Kagaku Ryoho; 2006 May; 33(5):625-9. PubMed ID: 16685161
[TBL] [Abstract][Full Text] [Related]
12. High expression of S-phase kinase-associated protein 2 (Skp2) is a strong prognostic marker in oral squamous cell carcinoma patients treated by UFT in combination with radiation.
Harada K; Supriatno ; Kawaguchi S; Kawashima Y; Itashiki Y; Yoshida H; Sato M
Anticancer Res; 2005; 25(3c):2471-5. PubMed ID: 16080478
[TBL] [Abstract][Full Text] [Related]
13. Predictive implications of nucleoside metabolizing enzymes in premenopausal women with node-positive primary breast cancer who were randomly assigned to receive tamoxifen alone or tamoxifen plus tegafur-uracil as adjuvant therapy.
Toi M; Ikeda T; Akiyama F; Kurosumi M; Tsuda H; Sakamoto G; Abe O
Int J Oncol; 2007 Oct; 31(4):899-906. PubMed ID: 17786323
[TBL] [Abstract][Full Text] [Related]
14. [Neoadjuvant chemotherapy with nedaplatin and UFT for oral squamous cell carcinomas].
Fujimori S; Kurita H; Azegami T; Koike T; Ohtsuka A; Kobayashi H; Tanaka K; Kurashina K
Gan To Kagaku Ryoho; 2003 May; 30(5):647-52. PubMed ID: 12795096
[TBL] [Abstract][Full Text] [Related]
15. Schedule-dependent synergism of vinorelbine and 5-fluorouracil/UFT against non-small cell lung cancer.
Matsumoto S; Igishi T; Hashimoto K; Kodani M; Shigeoka Y; Nakanishi H; Touge H; Kurai J; Makino H; Takeda K; Yasuda K; Hitsuda Y; Shimizu E
Int J Oncol; 2004 Nov; 25(5):1311-8. PubMed ID: 15492820
[TBL] [Abstract][Full Text] [Related]
16. Intratumoural expression of thymidylate synthase is an independent predictor of prognosis in patients with squamous cell carcinoma of the tongue: results from a retrospective study.
Kawano K; Yanagisawa S; Kusukawa J; Sunagawa H; Shiba R; Goto M; Shinohara M; Fukuda J; Oishi M; Ikemura K; Takahashi T; Sugihara K; Inokuchi T; Mimura T; Goto H
Int J Oral Maxillofac Surg; 2006 Mar; 35(3):258-64. PubMed ID: 16280240
[TBL] [Abstract][Full Text] [Related]
17. Comparison of 5-fluorouracil-related gene expression levels between adenocarcinomas and squamous cell carcinomas of the lung.
Ishihama H; Chida M; Araki O; Karube Y; Seki N; Tamura M; Umezu H; Honma K; Masawa N; Miyoshi S
Jpn J Clin Oncol; 2009 Jan; 39(1):33-6. PubMed ID: 19015148
[TBL] [Abstract][Full Text] [Related]
18. Dihydropyrimidine dehydrogenase expression predicts survival outcome and chemosensitivity to 5-fluorouracil in patients with oral squamous cell carcinoma.
Kobayashi H; Koike T; Nakatsuka A; Kurita H; Sagara J; Taniguchi S; Kurashina K
Oral Oncol; 2005 Jan; 41(1):38-47. PubMed ID: 15598584
[TBL] [Abstract][Full Text] [Related]
19. Phase II study of a novel oral formation of 5-fluorouracil in combination with low-dose cisplatin as preoperative chemotherapy of oral squamous cell carcinoma.
Nakazawa M; Ohnishi T; Ohmae M; Chisoku H; Yui S; Iwai S; Sumi T; Fukuda Y; Kishino M; Yura Y
Int J Clin Pharmacol Res; 2005; 25(3):115-22. PubMed ID: 16366419
[TBL] [Abstract][Full Text] [Related]
20. Effects of cepharanthine alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice.
Harada K; Ferdous T; Itashiki Y; Takii M; Mano T; Mori Y; Ueyama Y
Anticancer Res; 2009 Apr; 29(4):1263-70. PubMed ID: 19414373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
